Sarah Zielsdorf, MD, MS - Graves' Disease (2019 Conference) (LDN, low Dose Naltrexone)

Sarah Zielsdorf, MD, MS - Graves' Disease (2019 Conference) (LDN, low dose naltrexone)

Sarah Zielsdorf, MD discusses what Graves’ disease is, treatment strategies, related conditions and predisposing factors, and the work-up from a functional medicine standpoint